Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background Loss-of-function mutations in GRN cause frontotemporal lobar degeneration (FTLD). Patients with GRN mutations present with a uniform subtype of TAR DNA-binding protein 43 (TDP-43) pathology at autopsy (FTLD-TDP type A); however, age at onset and clinical presentation are variable, even within families. We aimed to identify potential genetic modifiers of disease onset and disease risk in GRN mutation carriers. Methods The study was done in three stages: a discovery stage, a replication stage, and a meta-analysis of the discovery and replication data. In the discovery stage, genome-wide logistic and linear regression analyses were done to test the association of genetic variants with disease risk (case or control status) and age at onset in patients with a GRN mutation and controls free of neurodegenerative disorders. Suggestive loci (p<1 × 10 −5 ) were genotyped in a replication cohort of patients and controls, followed by a meta-analysis. The effect of genome-wide significant variants at the GFRA2 locus on expression of GFRA2 was assessed using mRNA expression studies in cerebellar tissue samples from the Mayo Clinic brain bank. The effect of the GFRA2 locus on progranulin concentrations was studied using previously generated ELISA-based expression data. Co-immunoprecipitation experiments in HEK293T cells were done to test for a direct interaction between GFRA2 and progranulin. Findings Individuals were enrolled in the current study between Sept 16, 2014, and Oct 5, 2017. After quality control measures, statistical analyses in the discovery stage included 382 unrelated symptomatic GRN mutation carriers and 1146 controls free of neurodegenerative disorders collected from 34 research centres located in the USA, Canada, Australia, and Europe. In the replication stage, 210 patients (67 symptomatic GRN mutation carriers and 143 patients with FTLD without GRN mutations pathologically confirmed as FTLD-TDP type A) and 1798 controls free of neurodegenerative diseases were recruited from 26 sites, 20 of which overlapped with the discovery stage. No genome-wide significant association with age at onset was identified in the discovery or replication stages, or in the meta-analysis. However, in the case-control analysis, we replicated the previously reported TMEM106B association (rs1990622 meta-analysis odds ratio [OR] 0·54, 95% CI 0·46–0·63; p=3·54 × 10 −16 ), and identified a novel genome-wide significant locus at GFRA2 on chromosome 8p21.3 associated with disease risk (rs36196656 meta-analysis OR 1·49, 95% CI 1·30–1·71; p=1·58 × 10 −8 ). Expression analyses showed that the risk-associated allele at rs36196656 decreased GFRA2 mRNA concentrations in cerebellar tissue (p=0·04). No effect of rs36196656 on plasma and CSF progranulin concentrations was detected by ELISA; however, co-immunoprecipitation experiments in HEK293T cells did suggest a direct binding of progranulin and GFRA2. Interpretation TMEM106B-related and GFRA2-related pathways might be future targets for treatments for FTLD, but the biological interaction between progranulin and these potential disease modifiers requires further study. TMEM106B and GFRA2 might also provide opportunities to select and stratify patients for future clinical trials and, when more is known about their potential effects, to inform genetic counselling, especially for asymptomatic individuals. Funding National Institute on Aging, National Institute of Neurological Disorders and Stroke, Canadian Institutes of Health Research, Italian Ministry of Health, UK National Institute for Health Research, National Health and Medical Research Council of Australia, and the French National Research Agency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Known genetic modifiers of f-FTD disease progression were not included, such as specific mutations (for MAPT) and TMEM106B, a modifier of penetrance in GRN.2,40”
From Temporal order of clinical and biomarker changes in familial frontotemporal dementia (2022) · cites this paper as [40]
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citationThe GDNF family: Signalling, biological functions and therapeutic value
Airaksinen, M. S., & Saarma, M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn812 · Cited by 1,828
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationA harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R. A., Neumann, M., Baborie, A., Sampathu, D. M., Du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. Y. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,017
Self-citationCommon variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Van Deerlin, V. M., Sleiman, P. M. A., Martinez-Lage, M., Chen-Plotkin, A., Wang, L.-S., Graff-Radford, N. R., Dickson, D. W., Rademakers, R., Boeve, B. F., Grossman, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.536 · Cited by 579
Self-citationAdvances in understanding the molecular basis of frontotemporal dementia
Rademakers, R., Neumann, M., & Mackenzie, I. R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.117 · Cited by 412
Self-citationTMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
Finch, N., Carrasquillo, M. M., Baker, M., Rutherford, N. J., Coppola, G., DeJesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0e3b · Cited by 243
Self-citationChen-Plotkin, A. S., Unger, T. L., Gallagher, M. D., Bill, E., Kwong, L. K., Volpicelli-Daley, L., Busch, J. I., Akle, S., Grossman, M., Van Deerlin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0521-12.2012 · Cited by 230
Self-citationRademakers, R., Baker, M., Gass, J., Adamson, J., Huey, E. D., Momeni, P., Spina, S., Coppola, G., Karydas, A. M., Stewart, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70221-1 · Cited by 216
Self-citation
Cited by
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547
Self-citationAn update on genetic frontotemporal dementia
Greaves, C. V., & Rohrer, J. D. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09363-4 · Cited by 500
Self-citationMoore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., Van Deerlin, V. M., Warren, J. D., Fox, N. C., Rossor, M. N., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30394-1 · Cited by 313
Self-citationFrontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Self-citationGenetic Modifiers and Rare Mendelian Disease
Rahit, K. M. T. H., & Tarailo-Graovac, M. (2020) · Genes · doi:10.3390/genes11030239 · Cited by 167
Metadata
- Authors
- Pottier, C., Zhou, X., Perkerson, R. B., Baker, M., Jenkins, G. D., Serie, D. J., Ghidoni, R., Benussi, L., Binetti, G., López de Munain, A., Zulaica, M., Moreno, F., Le Ber, I., Pasquier, F., Hannequin, D., Sánchez-Valle, R., Antonell, A., Lladó, A., Parsons, T. M., Finch, N. A., Finger, E. C., Lippa, C. F., Huey, E. D., Neumann, M., Heutink, P., Synofzik, M., Wilke, C., Rissman, R. A., Slawek, J., Sitek, E., Johannsen, P., Nielsen, J. E., Ren, Y., van Blitterswijk, M., DeJesus-Hernandez, M., Christopher, E., Murray, M. E., Bieniek, K. F., Evers, B. M., Ferrari, C., Rollinson, S., Richardson, A., Scarpini, E., Fumagalli, G. G., Padovani, A., Hardy, J., Momeni, P., Ferrari, R., Frangipane, F., Maletta, R., Anfossi, M., Gallo, M., Petrucelli, L., Suh, E., Lopez, O. L., Wong, T. H., van Rooij, J. G. J., Seelaar, H., Mead, S., Caselli, R. J., Reiman, E. M., Noel Sabbagh, M., Kjolby, M., Nykjaer, A., Karydas, A. M., Boxer, A. L., Grinberg, L. T., Grafman, J., Spina, S., Oblak, A., Mesulam, M.-M., Weintraub, S., Geula, C., Hodges, J. R., Piguet, O., Brooks, W. S., Irwin, D. J., Trojanowski, J. Q., Lee, E. B., Josephs, K. A., Parisi, J. E., Ertekin-Taner, N., Knopman, D. S., Nacmias, B., Piaceri, I., Bagnoli, S., Sorbi, S., Gearing, M., Glass, J., Beach, T. G., Black, S. E., Masellis, M., Rogaeva, E., Vonsattel, J.-P., Honig, L. S., Kofler, J., Bruni, A. C., Snowden, J., Mann, D., Pickering-Brown, S., Diehl-Schmid, J., Winkelmann, J., Galimberti, D., Graff, C., Öijerstedt, L., Troakes, C., Al-Sarraj, S., Cruchaga, C., Cairns, N. J., Rohrer, J. D., Halliday, G. M., Kwok, J. B., van Swieten, J. C., White, C. L., Ghetti, B., Murell, J. R., Mackenzie, I. R. A., Hsiung, G.-Y. R., Borroni, B., Rossi, G., Tagliavini, F., Wszolek, Z. K., Petersen, R. C., Bigio, E. H., Grossman, M., Van Deerlin, V. M., Seeley, W. W., Miller, B. L., Graff-Radford, N. R., Boeve, B. F., Dickson, D. W., Biernacka, J. M., & Rademakers, R.
- Affiliations
- Mayo Clinic in Florida (US)
- Mayo Clinic (US)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- Instituto de Salud Carlos III (ES)
- Inserm (FR)
- Hospital Clínic de Barcelona (ES)
- Western University (CA)
- Thomas Jefferson University Hospital (US)
- Columbia University Irving Medical Center (US)
- German Center for Neurodegenerative Diseases (DE)
- University of California San Diego (US)
- Gdańsk Medical University (PL)
- University of Copenhagen (DK)
- The University of Texas Southwestern Medical Center (US)
- University of Manchester (GB)
- Salford Royal Hospital (GB)
- University of Milan (IT)
- University of Brescia (IT)
- UCL Queen Square Institute of Neurology (GB)
- University of Pennsylvania (US)
- Erasmus MC (NL)
- MRC Prion Unit (GB)
- Banner Alzheimer’s Institute (US)
- University of California, San Francisco (US)
- Northwestern University (US)
- Indiana University School of Medicine (US)
- The University of Sydney (AU)
- University of Florence (IT)
- Emory University (US)
- Banner Sun Health Research Institute (US)
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- University of Pittsburgh (US)
- TUM Klinikum (DE)
- Karolinska University Hospital (SE)
- King's College London (GB)
- Washington University in St. Louis (US)
- University of British Columbia (CA)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Corresponding author
- Rademakers, Rosa
- ORCID
- Pottier, Cyril
- Zhou, Xiaolai
- Baker, Matt
- Jenkins, Gregory D
- Ghidoni, Roberta
- Benussi, Luisa
- Binetti, Giuliano
- Zulaica, Miren
- Pasquier, Florence
- Hannequin, Didier
- Lladó, Albert
- Finger, Elizabeth C
- Lippa, Carol F
- Huey, Edward D
- Neumann, Manuela
- Heutink, Peter
- Synofzik, Matthis
- Wilke, Carlo
- Rissman, Robert A
- Sitek, Emilia
- Johannsen, Peter
- Nielsen, Jørgen E
- Ren, Yingxue
- Murray, Melissa E
- Bieniek, Kevin F
- Evers, Bret M
- Ferrari, Camilla
- Rollinson, Sara
- Richardson, Anna
- Scarpini, Elio
- Fumagalli, Giorgio G
- Padovani, Alessandro
- Hardy, John
- Ferrari, Raffaele
- Maletta, Raffaele
- Anfossi, Maria
- Gallo, Maura
- Petrucelli, Leonard
- Suh, EunRan
- Seelaar, Harro
- Mead, Simon
- Caselli, Richard J
- Reiman, Eric M
- Boxer, Adam L
- Grinberg, Lea T
- Grafman, Jordan
- Spina, Salvatore
- Oblak, Adrian
- Mesulam, M-Marsel
- Geula, Changiz
- Hodges, John R
- Piguet, Olivier
- Brooks, William S
- Irwin, David J
- Trojanowski, John Q
- Lee, Edward B
- Josephs, Keith A
- Knopman, David S
- Nacmias, Benedetta
- Piaceri, Irene
- Bagnoli, Silvia
- Sorbi, Sandro
- Gearing, Marla
- Glass, Jonathan
- Beach, Thomas G
- Black, Sandra E
- Masellis, Mario
- Rogaeva, Ekaterina
- Honig, Lawrence S
- Kofler, Julia
- Bruni, Amalia C
- Snowden, Julie
- Mann, David
- Pickering-Brown, Stuart
- Winkelmann, Juliane
- Galimberti, Daniela
- Graff, Caroline
- Öijerstedt, Linn
- Troakes, Claire
- Cruchaga, Carlos
- Cairns, Nigel J
- Rohrer, Jonathan D
- Halliday, Glenda M
- Kwok, John B
- White, Charles L
- Ghetti, Bernardino
- Mackenzie, Ian R A
- Hsiung, Ging-Yuek R
- Borroni, Barbara
- Rossi, Giacomina
- Tagliavini, Fabrizio
- Petersen, Ronald C
- Bigio, Eileen H
- Grossman, Murray
- Seeley, William W
- Miller, Bruce L
- Boeve, Bradley F
- Dickson, Dennis W
- Biernacka, Joanna M
- Rademakers, Rosa
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 17
- Issue
- 6
- Pages
- 548-558
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC6237181
- OpenAlex
- W2802484183
- Cited by
- 131
- References
- 24
- Citations by year
- 2026: 15 · 2025: 12 · 2024: 13 · 2023: 11 · 2022: 16 · 2021: 24 · 2020: 23 · 2019: 13 · 2018: 4
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- PMC
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- McCune Foundation
- Pfizer
- GHR Foundation
- Tau Consortium
- Mayo Clinic
- Sun Health Foundation
- National Institute of Neurological Disorders and Stroke (P01 NS084974, P30 NS055077, P50 NS072187, R01 NS076837, R01 NS080820, R35 NS097261, U24 NS072026, U54 NS092089)
- U.S. Department of Veterans Affairs (I01 BX003040)
- Michael J. Fox Foundation for Parkinson's Research
- National Institute on Aging (P30 AG019610)
- National Institute on Deafness and Other Communication Disorders (R01 DC008552)
- National Health and Medical Research Council (1037746, 1062539, 1095127)
- Wolfson Foundation
- Arizona Department of Health Services (211002)
- Deutsche Forschungsgemeinschaft
- Arizona Biomedical Research Commission (0011, 05-901, 4001)
- Alzheimer’s Research UK
- Bundesministerium für Bildung und Forschung (FTLDc O1GI1007A)
- Fondazione Telethon
- Biogen
- Celgene
- AbbVie
- Medical Research Council
- National Institute for Health and Care Research
- Roche
- Alzheimer's Society (G0701441)
- Sanofi
- Brain Research Trust
- Royal College of Physicians
- Genentech
- Merck
- Novartis
- Stockholms Läns Landsting
- NOMIS Stiftung
- Helmholtz Association
- Gdański Uniwersytet Medyczny
- UCLH Biomedical Research Centre
- Vetenskapsrådet (2015-02926, 521-2010-3134, 529-2014-7504)
- Else Kröner-Fresenius-Stiftung
- Ente Cassa di Risparmio di Firenze (2015-0722)
- EU Joint Programme – Neurodegenerative Disease Research (733051024)
- Ministero della Salute
- Centre of Excellence in Cognition and its Disorders, Australian Research Council (110001021, 630434)
- Karolinska Institutet
- Cancer Institute, University of Pittsburgh
- Fundació la Marató de TV3 (20143810, 70-73305-98-105)
- Gun och Bertil Stohnes Stiftelse
- School of Public Health, University of California Berkeley
- National Institutes of Health
- Associazione Italiana Ricerca Alzheimer
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- frontotemporal lobar degeneration, GRN mutations, progranulin, genetic modifiers, age of onset, GFRA2, TMEM106B, TDP-43 pathology, disease risk, loss-of-function mutations, neurodegenerative disease genetics, mutation carriers
- MeSH terms
- Progranulins, Aged, Cerebellum, Female, Humans, Male, Middle Aged, Mutation, RNA, Messenger, Case-Control Studies, Age of Onset, Genetic Predisposition to Disease, Glial Cell Line-Derived Neurotrophic Factor Receptors, Genome-Wide Association Study, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30126-1
- The paper
- Pottier, C., Zhou, X., Perkerson, R. B., Baker, M., Jenkins, G. D., Serie, D. J., Ghidoni, R., Benussi, L., Binetti, G., López de Munain, A., Zulaica, M., Moreno, F., Le Ber, I., Pasquier, F., Hannequin, D., Sánchez-Valle, R., Antonell, A., Lladó, A., Parsons, T. M., . . . Rademakers, R. (2018). Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30126-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.